Invention Grant
US07932389B2 Octahydropyrrolo[2,3C]pyridine derivatives and pharmaceutical use thereof
有权
八氢吡咯并[2,3C]吡啶衍生物及其药物用途
![Octahydropyrrolo[2,3C]pyridine derivatives and pharmaceutical use thereof](/docs/US/2011-04-26/US07932389B2/abs.jpg.600x600.jpg)
- Patent Title: Octahydropyrrolo[2,3C]pyridine derivatives and pharmaceutical use thereof
- Patent Title (中): 八氢吡咯并[2,3C]吡啶衍生物及其药物用途
-
Application No.: US11658084Application Date: 2005-07-20
-
Publication No.: US07932389B2Publication Date: 2011-04-26
- Inventor: Dominique Swinnen , Agnes Bombrun
- Applicant: Dominique Swinnen , Agnes Bombrun
- Applicant Address: CH Vaud
- Assignee: Merck Serono S.A.
- Current Assignee: Merck Serono S.A.
- Current Assignee Address: CH Vaud
- Agency: Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P.
- Priority: EP04103483 20040721
- International Application: PCT/EP2005/053501 WO 20050720
- International Announcement: WO2006/008303 WO 20060126
- Main IPC: C07D471/02
- IPC: C07D471/02
![Octahydropyrrolo[2,3C]pyridine derivatives and pharmaceutical use thereof](/abs-image/US/2011/04/26/US07932389B2/abs.jpg.150x150.jpg)
Abstract:
The present invention is related to octahydropyrrolo[2,3,c]pyridine derivatives of Formula (I) and use thereof in particular for the treatment and/or prophylaxis of autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, cancer, respiratory diseases and fibrosis, including multiple sclerosis, arthritis, emphysema, chronic obstructive pulmonary disease, liver and pulmonary fibrosis.
Public/Granted literature
- US20080146806A1 Octahydropyrrolo[2,3C]Pyridine Derivatives and Pharmaceutical Use Thereof Public/Granted day:2008-06-19
Information query
